Evaluation of the Validity of SAMe-TTR Score in a Cohort of Venous Thromboembolism Patients Treated With Warfarin
Low SAMe-TT 2 R 2 score of <2 was validated as a predictor of optimum anticoagulation control, reflected by mean time in therapeutic range (TTR) above 65% to 70%, among warfarin-treated atrial fibrillation patients. This study aimed to validate the ability of SAMe-TT 2 R 2 score and its individua...
Main Authors: | Eman Nawash Alhmoud MSc, BCPS, CPHQ, Hazem Elewa RPh, PhD, BCPS, Mohammed S. Abdul Gelil RPh, MSc, Osama B. Abd El Samad MSc, Abdelnasser Y. Elzouki MD, MSc, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-09-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/1076029620945039 |
Similar Items
-
Preemptive Dose Adjustment Effect on the Quality of Anticoagulation Management in Warfarin Patients With Drug Interactions: A Retrospective Cohort Study
by: Amr Mohamed Fahmi MClin Pharm, BCCP, et al.
Published: (2019-08-01) -
Uninterrupted dabigatran is safer than warfarin in patients undergoing ablation for atrial fibrillation
by: Michael Spartalis, MD, MSc, PhD, et al.
Published: (2017-12-01) -
The Effect of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in the MENA Region: A Systematic Review
by: Zainab Ali Msc, et al.
Published: (2019-09-01) -
Effects of Obesity on Warfarin Reversal With Vitamin K
by: Stanley A. Luc PharmD, BCPS, et al.
Published: (2019-01-01) -
Principal Component Analysis on Recurrent Venous Thromboembolism
by: Tiago D. Martins PhD, et al.
Published: (2019-12-01)